phenytoin has been researched along with sirolimus in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 4 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Beattie, TJ; Hodges, CB; Jindal, RM; Maxwell, H; Murphy, AV | 1 |
| Berarducci, M; Cutts, J; Dempsey, PK; Kadish, SP; Lee, G; Thomas, C | 1 |
| Fridell, JA; Fung, JJ; Jain, AK; Patel, K; Rao, KN; Venkataramanan, R; Virji, M | 1 |
| Chi, X; Huang, C; Li, J; Li, R; Wang, W; Wu, M; Zhou, D | 1 |
| Del Priore, G; Hoffman, S; Noel, MS; Stega, D; Stega, J; Vandell, AG | 1 |
| Del Priore, G; Gartrell, BA; Retter, A; Roach, M; Scher, HI; Sokol, GH | 1 |
| Chung, V; Hartley, ML; Kim, DW; Kim, S; Noel, MS; Ocean, AJ; Philip, PA; Picozzi, VJ; Staszewski, H; Van Tornout, JM; Wang-Gillam, A; Wong, S | 1 |
| Bernard, SA; Boilson, BA; Lemke, AI; Razonable, RR | 1 |
1 review(s) available for phenytoin and sirolimus
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for phenytoin and sirolimus
| Article | Year |
|---|---|
A first-in-human study of the novel metabolism-based anti-cancer agent SM-88 in subjects with advanced metastatic cancer.
Topics: Aged; alpha-Methyltyrosine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Exanthema; Female; Humans; Hyperpigmentation; Male; Melanins; Middle Aged; Neoplasms; Phenytoin; Pilot Projects; Quality of Life; Sirolimus; Survival Analysis | 2020 |
Phase II trial of SM-88, a cancer metabolism based therapy, in non-metastatic biochemical recurrent prostate cancer.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Humans; Kaplan-Meier Estimate; Male; Methoxsalen; Middle Aged; Neoplasm Recurrence, Local; Phenytoin; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Sirolimus; Tyrosine | 2021 |
A randomized phase II study of SM-88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Humans; Methoxsalen; Pancreatic Neoplasms; Phenytoin; Quality of Life; Sirolimus | 2022 |
7 other study(ies) available for phenytoin and sirolimus
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Use of rapamycin in a transplant patient who developed cyclosporin neurotoxicity.
Topics: Anticonvulsants; Child; Cyclosporine; Cytochrome P-450 Enzyme System; Enzyme Induction; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Phenytoin; Seizures; Sirolimus | 2001 |
Goosebumps.
Topics: Astrocytoma; Brain Neoplasms; Carmustine; Dexamethasone; Diagnosis, Differential; Frontal Lobe; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Phenytoin; Piloerection; Seizures; Sirolimus; Taste Disorders; Temporal Lobe | 2002 |
Phenytoin decreases the blood concentrations of sirolimus in a liver transplant recipient: a case report.
Topics: Area Under Curve; Drug Interactions; Female; Graft Rejection; Humans; Liver Transplantation; Middle Aged; Phenytoin; Sirolimus | 2003 |
Inhibition of mTOR Pathway by Rapamycin Decreases P-glycoprotein Expression and Spontaneous Seizures in Pharmacoresistant Epilepsy.
Topics: Adult; Animals; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Case-Control Studies; Drug Resistant Epilepsy; Female; Humans; Lactones; Male; Phenytoin; Rats; Rats, Sprague-Dawley; Seizures; Sirolimus; TOR Serine-Threonine Kinases | 2017 |
Phenytoin to expedite sirolimus and tacrolimus elimination.
Topics: Humans; Immunosuppressive Agents; Kidney Transplantation; Phenytoin; Sirolimus; Tacrolimus | 2022 |